Stem Cell Transplant Adverse Reactions (STAR) Analysis: Does a Higher Infusion Red Blood Cell Content Correlate with Serious Adverse Events?stem cell transplantcaregiverscoping strategies and educationWe report herein the patterns of type 1 diabetes recurrence in a simultaneous pancreas-kidney transplant ...
Doner lymphocyte infusionSummary Haemopoietic stem cell transplantation (SCT) represents an important and increasingly utilized curative therapy in haematological malignancies and has an emerging role in the management of patients with haemoglobinopathies and bone marrow failure. (Figure 1) Autologous ...
Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness Infusion of either embryonic or mesenchymal stem cells prolongs the survival of organ transplants derived from stem cell donors and prevents graft-versus-h... Beyth,S. - 《Blood》 被引量: 2454...
Cell therapy bydonor lymphocyte infusion 2. Non-myeloablativestem cell transplantation(NST); the ‘mini-transplant transplant’ program 3. Methods and preliminary results 3.1. The non-myeloablative stem cell transplantation protocol 3.2. Clinical application of NST ...
Once the stem cell products are ready, the doctors administer them by the following methods, depending on the treatment program: Intravenous infusion; Intrathecal, intradermal, intramuscular, intra-articular, paravertebral, retrobulbar, parameatal, penile injections; ...
Kao, Paradoxical embolism after peripheral blood stem cell infusion. Bone Marrow Transplantation 36 (2005) 560-562.Darabi K, Brown JR, Kao GS. Paradoxical embolism after pe- ripheral blood stem cell infusion. Bone Marrow Transplant. 2005;36(6):561-562....
This trial evaluated the feasibility and efficacy of the infusion of mesenchymal stem cells expanded using human serum for the treatment of refractory acut... JA Perez-Simon,O Lopez-Villar,EJ Andreu,... - 《Haematologica》 被引量: 194发表: 2011年 Stem cell transplantation for chronic lymphocyti...
Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL. Bone Marrow Transplant. 2014;49:287–91. https://doi.org/10.1038/bmt.2013.111 Article CAS PubMed Google Scholar Saad A, Lamb LS....
further investigation. Despite their high curative efficacy, MSC therapy has some drawbacks, such as difficulty in generating a consistent source of cells with a stable phenotype, infusion-related toxicities resulting from the cells physically trapped in the lung microvasculature, and others [7,8,9,...
An autologous transplant is one in which the donor and recipient are the same. Cells are harvested from the patient when he or she is healthy or in complete remission, and they are frozen and stored for future reinfusion. Patient Preparation Before the SCT, the recipient's body is deliberat...